Cilastatin 250 mg/ML / imipenem 250 mg/ML Injectable Solution [Primaxin]
RxNorm 849604

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 849604 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cilastatin 250 mg/ML / imipenem 250 mg/ML Injectable Solution [Primaxin].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Cilastatin 250 mg/ML / imipenem 250 mg/ML Injectable Solution [Primaxin]
AUI:12365486
View
SY
Primaxin IM (cilastatin 2.5 mg/ML / imipenem 2.5 mg/ML) Injectable Solution
AUI:2969251
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Cilastatin 250 mg/ML / imipenem 250 mg/ML Injectable Solution [Primaxin]
(Atom ID: 12365486)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
cilastatin 250 MG/ML / imipenem 250 MG/ML Injectable Solution [Primaxin]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
849604
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12365486
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
849604
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Sol
The RxTerm dose form name for this drug
SY

Synonym (SY):
Primaxin IM (cilastatin 2.5 mg/ML / imipenem 2.5 mg/ML) Injectable Solution
(Atom ID: 2969251)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Primaxin IM (cilastatin 2.5 MG/ML / imipenem 2.5 MG/ML) Injectable Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
849604
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
2969251
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
849604
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.